Literature DB >> 29383530

Microvascular Coronary Dysfunction-an Overview.

Sahar Naderi1.   

Abstract

PURPOSE OF REVIEW: We will review the available data on the epidemiology, pathophysiology, diagnosis, and management of microvascular coronary dysfunction (MCD). RECENT
FINDINGS: The study of MCD was pioneered by the Women's Ischemia Syndrome Evaluation (WISE) cohort. New techniques in the diagnosis of this condition, using invasive and noninvasive means, are helping to increase awareness of this condition as well as ways in which to treat it. Microvascular coronary disease without epicardial involvement has become an increasingly recognized cause of cardiac chest pain, particularly in women. Dysfunction of the microvasculature related to endothelium-dependent and endothelial-independent factors likely results in symptoms and/or evidence of ischemia. Although there is a growing body of research, there is still much about MCD that we do not understand.

Entities:  

Keywords:  Microvascular disease; Microvascular dysfunction; Women’s heart disease

Mesh:

Year:  2018        PMID: 29383530     DOI: 10.1007/s11883-018-0710-5

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  39 in total

1.  Novel index for invasively assessing the coronary microcirculation.

Authors:  William F Fearon; Leora B Balsam; H M Omar Farouque; Anthony D Caffarelli; Robert C Robbins; Peter J Fitzgerald; Paul G Yock; Alan C Yeung
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

2.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

Authors:  J A Suwaidi; S Hamasaki; S T Higano; R A Nishimura; D R Holmes; A Lerman
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

3.  Coronary arteriolar myogenic response is independent of endothelium.

Authors:  L Kuo; W M Chilian; M J Davis
Journal:  Circ Res       Date:  1990-03       Impact factor: 17.367

4.  In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).

Authors:  Daniel F Pauly; B Delia Johnson; R David Anderson; Eileen M Handberg; Karen M Smith; Rhonda M Cooper-DeHoff; George Sopko; Barry M Sharaf; Sheryl F Kelsey; C Noel Bairey Merz; Carl J Pepine
Journal:  Am Heart J       Date:  2011-09-06       Impact factor: 4.749

5.  Deaths: Final Data for 2014.

Authors:  Kenneth D Kochanek; Sherry L Murphy; Jiaquan Xu; Betzaida Tejada-Vera
Journal:  Natl Vital Stat Rep       Date:  2016-06

Review 6.  The coronary circulation and blood flow in left ventricular hypertrophy.

Authors:  Paolo G Camici; Iacopo Olivotto; Ornella E Rimoldi
Journal:  J Mol Cell Cardiol       Date:  2011-09-05       Impact factor: 5.000

7.  Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events.

Authors:  Lasse Jespersen; Anders Hvelplund; Steen Z Abildstrøm; Frants Pedersen; Søren Galatius; Jan K Madsen; Erik Jørgensen; Henning Kelbæk; Eva Prescott
Journal:  Eur Heart J       Date:  2011-09-11       Impact factor: 29.983

Review 8.  Calcium antagonists and ACE inhibitors. Effect on endothelium and vascular smooth muscle.

Authors:  T F Lüscher; Z Yang
Journal:  Drugs       Date:  1993       Impact factor: 9.546

9.  Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial).

Authors:  D J Diver; J D Bier; P E Ferreira; B L Sharaf; C McCabe; B Thompson; B Chaitman; D O Williams; E Braunwald
Journal:  Am J Cardiol       Date:  1994-09-15       Impact factor: 2.778

10.  Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study.

Authors:  Naja Dam Mygind; Marie Mide Michelsen; Adam Pena; Daria Frestad; Nynne Dose; Ahmed Aziz; Rebekka Faber; Nis Høst; Ida Gustafsson; Peter Riis Hansen; Henrik Steen Hansen; C Noel Bairey Merz; Jens Kastrup; Eva Prescott
Journal:  J Am Heart Assoc       Date:  2016-03-15       Impact factor: 5.501

View more
  5 in total

1.  Perspective: cardiovascular disease and the Covid-19 pandemic.

Authors:  Tommaso Gori; Jos Lelieveld; Thomas Münzel
Journal:  Basic Res Cardiol       Date:  2020-04-10       Impact factor: 17.165

2.  Three-dimensional alignment of microvasculature and cardiomyocytes in the developing ventricle.

Authors:  Maryse Lapierre-Landry; Hana Kolesová; Yehe Liu; Michiko Watanabe; Michael W Jenkins
Journal:  Sci Rep       Date:  2020-09-11       Impact factor: 4.379

Review 3.  Inflammation in Coronary Microvascular Dysfunction.

Authors:  Marios Sagris; Panagiotis Theofilis; Alexios S Antonopoulos; Evangelos Oikonomou; Christina Paschaliori; Nikolaos Galiatsatos; Kostas Tsioufis; Dimitris Tousoulis
Journal:  Int J Mol Sci       Date:  2021-12-15       Impact factor: 5.923

Review 4.  Sex differences in acute cardiovascular care: a review and needs assessment.

Authors:  Saraschandra Vallabhajosyula; Dhiran Verghese; Viral K Desai; Pranathi R Sundaragiri; Virginia M Miller
Journal:  Cardiovasc Res       Date:  2022-02-21       Impact factor: 10.787

Review 5.  Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker?

Authors:  Jing Liu; Salim S Virani; Mahboob Alam; Ali E Denktas; Ihab Hamzeh; Umair Khalid
Journal:  Rev Med Virol       Date:  2020-09-22       Impact factor: 11.043

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.